Merit Medical Systems | MMSI - Betriebsergebnis

Aktienkurs
68.24
Täglich Wechseln
3.40 5.24%
Monatlich
-1.00%
Jährlich
-26.78%
Q2 Prognose
67.11




Betriebsergebnis Veränderung Datum
3M USD 1.55B 337M 2026-03
Abbott USD 1.85B 399M 2026-03
AngioDynamics USD -2.51M 5.41M 2025-09
Anika Therapeutics USD 646K 3.88M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Olympus JPY 28B 5.56B 2025-12
Pfizer USD 4.65B 3.99B 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Stryker USD 1.97B 609M 2025-12
Surmodics USD 58K 5.7M 2025-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03